Inflammatory cells, cytokines and matrix metalloproteinases in amicrobial pustulosis of the folds and other neutrophilic dermatoses

International Journal of Immunopathology and Pharmacology

Volumn 24, Issue 2, 2011, Pages 451-460

  Marzano, A V ^a   Cugno, Massimo ^a   Trevisan, V ^a   Lazzari, R ^a   Fanoni, D ^a   Berti, E ^a   Crosti, C ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Amicrobial pustulosis of the folds; Cytokines; Metalloproteinases; Neutrophilic dermatoses; Vascular endothelial growth factor

Indexed keywords

CD163 ANTIGEN; CD3 ANTIGEN; GELATINASE A; GELATINASE B; INTERLEUKIN 17; INTERLEUKIN 8; MYELOPEROXIDASE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; CYTOKINE; MATRIX METALLOPROTEINASE; AUTACOID; CELL SURFACE RECEPTOR; DIFFERENTIATION ANTIGEN; IL8 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; MMP2 PROTEIN, HUMAN; PEROXIDASE; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ACUTE FEBRILE NEUTROPHILIC DERMATOSIS; ADOLESCENT; ADULT; AGED; AMICROBIAL PUSTULOSIS OF THE FOLDS; ARTICLE; CD3+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFLAMMATORY CELL; PRIORITY JOURNAL; PUSTULOSIS; PYODERMA GANGRENOSUM; SKIN DEFECT; SKINFOLD; CYTOKINE RELEASE; DISEASE DURATION; INFLAMMATORY INFILTRATE; MALE; PHENOTYPE; PROTEIN EXPRESSION; BIOPSY; CASE CONTROL STUDY; ENZYMOLOGY; IMMUNOLOGY; IMMUNOPHENOTYPING; MIDDLE AGED; NEUTROPHIL; PATHOLOGY; PSORIASIS; SKIN;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD; ANTIGENS, CD3; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BIOPSY; CASE-CONTROL STUDIES; CYTOKINES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; INFLAMMATION MEDIATORS; INTERLEUKIN-17; INTERLEUKIN-8; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NEUTROPHILS; PEROXIDASE; PHENOTYPE; PSORIASIS; PYODERMA GANGRENOSUM; RECEPTORS, CELL SURFACE; SKIN; SWEET SYNDROME; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 80051729507     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201102400218     Document Type: Article

References (30)

1. Crickx B, Diego ML, Guillevin L, Piccard C, Grossin M, Bélaîch S. Pustulose amicrobienne et lupus erythémateux systemique. Journées Dermatol paris 1991; Communication No 11.
2. Marzano AV, Capsoni F, Berti E, Gasparini G, Bottelli S, Caputo R. Amicrobial pustular dermatosis of cutaneous folds associated with autoimmune disorders: a new entity? Dermatology 1996; 193:88-93. (Pubitemid 26297388)
3. Lopez Estebaranz JL, Vanaclocha Sebastian F, Iglesias Diez L. Non-microbial pustulosis and systemic lupus erythematosus. Ann Dermatol Venereol 1996; 123:401-02. (Pubitemid 26242696)
4. Lagrange S, Chosidow O, Piette JC, Wechsler B, Godeau P, Frances C. A peculiar form of amicrobial pustulosis of the folds associated with systemic lupus erythematosus and other autoimmune diseases. Lupus 1997; 6:514-20. (Pubitemid 27371219)
5. Inui S, Azukizawa H, Asada H, Itami S. Amicrobial pustulosis with antinuclear antibodies and rheumatoid factor. Br J Dermatol 2006; 154:568-69. (Pubitemid 43382680)
6. Marzano AV, Ramoni S, Caputo R. Amicrobial pustulosis of the folds. Report of 6 cases and a literature review. Dermatology 2008; 216:305-11. (Pubitemid 351630094)
7. Schröder JM, Szperalski B, Koh CJ, Christophers E. IgA-associated inhibition of polymorphonuclear leukocyte Chemotaxis in neutrophilic dermatoses. J Invest Dermatol 1981; 77:464-68. (Pubitemid 12250441)
8. Vignon-Pennamen MD, Wallach D. Cutaneous manifestations of neutrophilic disease: a study of seven cases. Dermatologica 1991; 183:255-64.
9. Antille C, Frei M, Sorg O, Tran C, Kaya G, Masouyé I, Fontao L, Prins C, Saurat JH. Amicrobial pustulosis of the folds associated with auto-immune disorders. A case report with an analysis of cytokine expression profile in skin lesions of cutaneous neutrophilic lupus. Dermatology 2008; 216:324-29. (Pubitemid 351630098)
10. Gunduz K, Demireli P, Inanir I, Nese N. Expression of matrix metalloproteinases (MMP-2, MMP-3, and MMP-9) and fibronectin in lichen planus. J Cutan Pathol 2006; 33:545-50. (Pubitemid 44213855)
11. Marzano AV, Tourlaki A, Alessi E, Caputo R. Widespread idiopathic pyoderma gangrenosum evolved from ulcerative to vegetative type: a 10-year history with a recent response to infliximab. Clin Exp Dermatol 2008; 33:156-59. (Pubitemid 351197208)
12. Cohen PR. Neutrophilic dermatoses: a review of current treatment options. Am J Clin Dermatol 2009; 10:301-12.
13. Gambichler T, Boms S, Hochdorfer B, Altmeyer P, Kreuter A. Immunohistology of amicrobial pustulosis of the folds. Clin Exp Dermatol 2007; 32:155-58. (Pubitemid 46233018)
14. Marzano AV, Cugno M, Trevisan V, Fanoni D, Venegoni L, Berti E, Crosti C. Role of inflammatory cells, cytokines and matrix metalloproteinases in neutrophil-mediated skin diseases. Clin Exp Immunol 2010; 162:100-07.
15. Reguiai Z, Grange F. The role of anti-tumor necrosis factor-alpha therapy in Pyoderma gangrenosum associated with inflammatory bowel disease. Am J Clin Dermatol 2007; 8:67-77. (Pubitemid 46998549)
16. Oppenheim JJ, Zachariae CO, Mukaida N, Matsushima K. Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu Rev Immunol 1991; 9:617-48.
17. Oka M, Berking C, Nesbit M, Satyamoorthy K, Schaider H, Murphy G, Ichihashi M, Sauter E, Herlyn M. Interleukin-8 overexpression is present in pyoderma gangrenosum ulcers and leads to ulcer formation in human skin xenografts. Lab Invest 2000; 80:595-04.
18. Saito S, Yasui K, Hosoda W, Ogawa M, Kobayashi N, Sakashita K, Koike K. CD30+ anaplastic large cell lymphoma complicated by pyoderma gangrenosum with increased levels of serum cytokines. Eur J Haematol 2006; 77:251-54. (Pubitemid 44181389)
19. Pene J, Chevalier S, Preisser L, et al. Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes. J Immunol 2008; 180:7423-30.
20. Tanasescu C, Balanescu E, Balanescu P, et al. IL-17 in cutaneous lupus erythematosus. Eur J Intern Med 2010; 21:202-07.
21. Miossec P, Korn T, Kuchroo VK. Interleukin-17 and type 17 helper T cells. N Engl J Med 2009; 361:888-98.
22. Nalbandian A, Crispin JC, Tsokos GC. Interleukin-17 and systemic lupus erythematosus: current concepts. Clin Exp Immunol 2009; 157:209-15.
23. Albanesi C, Cavani A, Girolomoni G. IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: synergistic or antagonist effects with IFN-gamma and TNF-alpha. J Immunol 1999; 162:494-502. (Pubitemid 29018959)
24. Ruddy MJ, Wong GC, Liu XK, Yamamoto H, Kasayama S, Kirkwood KL, Gaffen SL. Functional cooperation between interleukin-17 and tumor necrosis factor-alpha is mediated by CCAAT/enhancer-binding protein family members. J Biol Chem 2004; 279:2559-67. (Pubitemid 38114241)
25. Agarwal S, Misra R, Aggarwal A. Interleukin 17 levels are increased in juvenile idiopathic arthritis synovial fluid and induce synovial fibroblasts to produce proinflammatory cytokines and matrix metalloproteinases. J Rheumatol 2008; 35:515-19. (Pubitemid 351374430)
26. Shapiro SD. Matrix metalloproteinase degradation of extracellular matrix: biological consequences. Curr Opin Cell Biol 1998; 10:602-08. (Pubitemid 28477018)
27. Vincenti MP. The matrix metalloproteinase (MMP) and tissue inhibitor of metalloproteinase (TIMP) genes. Transcriptional and posttranscriptional regulation, signal transduction and cell-type-specific expression. Methods Mol Biol 2001; 151:121-48.
28. Delclaux C, Delacourt C, D'Ortho MP, Boyer V, Lafuma C, Harf A. Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across basement membrane. Am J Resp Cell Mol Biol 1996; 14:288-95. (Pubitemid 126439823)
29. Gao Q, Meijer MJ, Kubben FJ. Expression of matrix metalloproteinases-2 and -9 in intestinal tissue of patients with inflammatory bowel diseases. Dig Liver Dis 2005; 37:584-92. (Pubitemid 44356072)
30. Zittermann SI, Issekutz AC. Endothelial growth factors VEGF and bFGF differentially enhance monocyte and neutrophil recruitment to inflammation. J Leukoc Biol 2006; 80:247-57. (Pubitemid 44835498)